Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations† (Englisch)
- Neue Suche nach: Decoster, L.
- Neue Suche nach: Van Puyvelde, K.
- Neue Suche nach: Mohile, S.
- Neue Suche nach: Wedding, U.
- Neue Suche nach: Basso, U.
- Neue Suche nach: Colloca, G.
- Neue Suche nach: Rostoft, S.
- Neue Suche nach: Overcash, J.
- Neue Suche nach: Wildiers, H.
- Neue Suche nach: Steer, C.
- Neue Suche nach: Decoster, L.
- Neue Suche nach: Van Puyvelde, K.
- Neue Suche nach: Mohile, S.
- Neue Suche nach: Wedding, U.
- Neue Suche nach: Basso, U.
- Neue Suche nach: Colloca, G.
- Neue Suche nach: Rostoft, S.
- Neue Suche nach: Overcash, J.
- Neue Suche nach: Wildiers, H.
- Neue Suche nach: Steer, C.
In:
ANNALS OF ONCOLOGY
;
26
, 2
;
288-300
;
2015
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†
-
Beteiligte:Decoster, L. ( Autor:in ) / Van Puyvelde, K. ( Autor:in ) / Mohile, S. ( Autor:in ) / Wedding, U. ( Autor:in ) / Basso, U. ( Autor:in ) / Colloca, G. ( Autor:in ) / Rostoft, S. ( Autor:in ) / Overcash, J. ( Autor:in ) / Wildiers, H. ( Autor:in ) / Steer, C. ( Autor:in )
-
Erschienen in:ANNALS OF ONCOLOGY ; 26, 2 ; 288-300
-
Verlag:
- Neue Suche nach: OXFORD UNIVERSITY PRESS
-
Erscheinungsdatum:01.01.2015
-
Format / Umfang:13 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.992
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.992 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 26, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 259
-
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014Salgado, R. / Denkert, C. / Demaria, S. / Sirtaine, N. / Klauschen, F. / Pruneri, G. / Wienert, S. / Van den Eynden, G. / Baehner, F. L. / Penault-Llorca, F. et al. | 2015
- 272
-
Cardiorespiratory fitness as predictor of cancer mortality: a systematic review and meta-analysisSchmid, D. / Leitzmann, M. F. et al. | 2015
- 278
-
Concurrent systemic therapy with radiotherapy for the treatment of poor-risk patients with unresectable stage III non-small-cell lung cancer: a review of the literatureCardenal, F. / Nadal, E. / Jové, M. / Faivre-Finn, C. et al. | 2015
- 288
-
Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†Decoster, L. / Van Puyvelde, K. / Mohile, S. / Wedding, U. / Basso, U. / Colloca, G. / Rostoft, S. / Overcash, J. / Wildiers, H. / Steer, C. et al. | 2015
- 300
-
Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paperCasali, P. G. / Bruzzi, P. / Bogaerts, J. / Blay, J. Y. et al. | 2015
- 307
-
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapyMontagna, E. / Bagnardi, V. / Viale, G. / Rotmensz, N. / Sporchia, A. / Cancello, G. / Balduzzi, A. / Galimberti, V. / Veronesi, P. / Luini, A. et al. | 2015
- 313
-
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12Gnant, M. / Mlineritsch, B. / Stoeger, H. / Luschin-Ebengreuth, G. / Knauer, M. / Moik, M. / Jakesz, R. / Seifert, M. / Taucher, S. / Bjelic-Radisic, V. et al. | 2015
- 320
-
Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH studyJackisch, C. / Kim, S. B. / Semiglazov, V. / Melichar, B. / Pivot, X. / Hillenbach, C. / Stroyakovskiy, D. / Lum, B. L. / Elliott, R. / Weber, H. A. et al. | 2015
- 325
-
Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 studyBonnefoi, H. / Jacot, W. / Saghatchian, M. / Moldovan, C. / Venat-Bouvet, L. / Zaman, K. / Matos, E. / Petit, T. / Bodmer, A. / Quenel-Tueux, N. et al. | 2015
- 332
-
Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancerSunakawa, Y. / Stremitzer, S. / Cao, S. / Zhang, W. / Yang, D. / Wakatsuki, T. / Ning, Y. / Yamauchi, S. / Stintzing, S. / Sebio, A. et al. | 2015
- 340
-
FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trialHebbar, M. / Chibaudel, B. / André, T. / Mineur, L. / Smith, D. / Louvet, C. / Dutel, J. L. / Ychou, M. / Legoux, J. L. / Mabro, M. et al. | 2015
- 368
-
Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal eventsSmith, M. R. / Coleman, R. E. / Klotz, L. / Pittman, K. / Milecki, P. / Ng, S. / Chi, K. N. / Balakumaran, A. / Wei, R. / Wang, H. et al. | 2015
- 374
-
Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapyVidal, A. D. / Thalmann, G. N. / Karamitopoulou-Diamantis, E. / Fey, M. F. / Studer, U. E. et al. | 2015
- 407
-
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment†Whelan, J. S. / Bielack, S. S. / Marina, N. / Smeland, S. / Jovic, G. / Hook, J. M. / Krailo, M. / Anninga, J. / Butterfass-Bahloul, T. / Böhling, T. et al. | 2015
- 415
-
Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trialMenzies, A. M. / Ashworth, M. T. / Swann, S. / Kefford, R. F. / Flaherty, K. / Weber, J. / Infante, J. R. / Kim, K. B. / Gonzalez, R. / Hamid, O. et al. | 2015
- 422
-
A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trialsDoussau, A. / Thiébaut, R. / Geoerger, B. / Schöffski, P. / Floquet, A. / Le Deley, M. C. / Mathoulin-Pélissier, S. / Rizzo, E. / Fumoleau, P. / Le Tourneau, C. et al. | 2015
- 428
-
Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosisBarrera, L. / Montes-Servín, E. / Barrera, A. / Ramírez-Tirado, L. A. / Salinas-Parra, F. / Bañales-Méndez, J. L. / Sandoval-Ríos, M. / Arrieta, . et al. | 2015
- 436
-
T-DM1-related telangiectasias: a potential role in secondary bleeding eventsSibaud, V. / Vigarios, E. / Combemale, P. / Lamant, L. / Lacouture, M. E. / Lacaze, J. L. / Dalenc, F. / Delord, J. P. et al. | 2015
- 437
-
Withdrawal of hormone replacement therapy might affect multigene signature results in early luminal breast cancerNeven, P. / Jongen, L. / Van Asten, K. / Berteloot, P. / Floris, G. / Wildiers, H. et al. | 2015
- 439
-
Can obesity be an advantage for febrile neutropenia?Alkan, A. / Bir, K. / Utkan, G. et al. | 2015
- 440
-
The obesity and cancer linkBifulco, M. et al. | 2015
- 441
-
The harms of low-dose aspirin prophylaxis are overstatedElwood, P. / Morgan, G. et al. | 2015
- 442
-
Reply to the letter to the editor ‘The harms of low-dose aspirin prophylaxis are overstated’ by P. Elwood and G. MorganThorat, M. A. / Cuzick, J. et al. | 2015
- 443
-
Albumin to globulin ratio, a predictor or a misleader?Alkan, A. / Köksoy, E. B. / Utkan, G. et al. | 2015
- 445
-
Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumorsSoria, J. C. / DeBraud, F. / Bahleda, R. / Adamo, B. / Andre, F. / Dienstmann, R. / Delmonte, A. / Cereda, R. / Isaacson, J. / Litten, J. et al. | 2015
- 445
-
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features| 2015